BridgeBio Oncology Therapeutics, In (BBOT) PT Lowered to $22 at Oppenheimer
Tweet
Share
E-mailGet Alerts BBOT Hot Sheet
Price: $9.06 -1.84%
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Oppenheimer analyst Matt Biegler lowered the price target on BridgeBio Oncology Therapeutics, In (NASDAQ: BBOT) to $22.00 (from $23.00) while maintaining a Outperform rating.
You May Also Be Interested In
- BridgeBio Oncology Therapeutics, In (BBOT) PT Lowered to $25 at JPMorgan
- LG Electronics India (LGEL:IN) PT Raised to INR1,815 at ICICI Securities
- Honasa Consumer Ltd (HONASA:IN) PT Raised to INR720 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
